High apoptotic activity and low epithelial cell proliferation with underexpression of p21WAF1/CIP1 and p27Kip1 of mucinous carcinomas of the colorectum -: Comparison with well-differentiated type

被引:18
作者
Akino, F
Mitomi, H
Nakamura, T
Ohtani, Y
Ichinoe, M
Okayasu, I
机构
[1] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 2288555, Japan
[2] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 2288555, Japan
关键词
colorectal neoplasm; mucinous carcinoma; apoptosis; cell cycle; p21(WAF1/CIP1); P27(Kip1); immunohistochemistry c-Ki-ras;
D O I
10.1309/D4QM-379U-E8J2-9R1M
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We comparatively assessed 41 mucinous colorectal carcinomas (MUCs) and 620 non-MUC (well-, moderately, and poorly differentiated adenocarcinoma) cases for clinicopathologic findings; and 41 MUCs and 115 randomly selected non-MUCs also were studied for the following: (1) apoptotic activity and Ki-67 immunoreactivity: (2) immunohistochemical expression of p21(WAF1/CIP1), p27(Kip1), p53, and bcl-2; and (3) c-Ki-ras mutations. The rates for lymph node involvement and peritoneal dissemination were higher in MUCs than in non-MUCs. Multivariate analysis showed MUCs to have a worse prognosis than well-differentiated adenocarcinomas. The Ki-67 labeling,for MUCs was Significantly lower than that for non-MUCs, whereas the apoptotic index was significantly higher than for the well-differentiated type. The labeling for p21(WAF1/CIP1) and p27(Kip1) was lower in MUCs (2.7% and 35.3%, respectively) than in well-differentiated adenocarcinomas (4.2% and 48.6%, respectively). MUCs can be considered a different tumor from the well-differentiated type, with a poor prognosis owing to frequently lymph node metastasis and peritoneal dissemination, and characterized by, high apoptotic and low proliferative activities associated with low p21(WAF1/CIP1) and p27(Kip1) expression.
引用
收藏
页码:908 / 915
页数:8
相关论文
共 41 条
[1]   INSITU END-LABELING DETECTS DNA STRAND BREAKS IN APOPTOSIS AND OTHER PHYSIOLOGICAL AND PATHOLOGICAL STATES [J].
ANSARI, B ;
COATES, PJ ;
GREENSTEIN, BD ;
HALL, PA .
JOURNAL OF PATHOLOGY, 1993, 170 (01) :1-8
[2]  
CAMPO E, 1991, CANCER RES, V51, P4436
[3]  
Ciaparrone M, 1998, CANCER RES, V58, P114
[4]   Cell cycle and cancer: Critical events at the G1 restriction point [J].
DelSal, G ;
Loda, M ;
Pagano, M .
CRITICAL REVIEWS IN ONCOGENESIS, 1996, 7 (1-2) :127-142
[5]  
Doglioni C, 1996, J PATHOL, V179, P248, DOI 10.1002/(SICI)1096-9896(199607)179:3<248::AID-PATH571>3.0.CO
[6]  
2-6
[7]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[8]  
ENOMOTO T, 1991, AM J PATHOL, V139, P777
[9]   A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[10]   Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis [J].
Frankfurt, OS ;
Robe, JA ;
Sugarbaker, EV ;
Villa, L .
EXPERIMENTAL CELL RESEARCH, 1996, 226 (02) :387-397